Can I use Otrivin (xylometazoline 0.1% nasal drops) safely during pregnancy?

Otrivin (Xylometazoline) Use in Pregnancy

Otrivin nasal drops should be avoided during pregnancy, or used only for short-term relief (maximum 3-7 days) when safer alternatives have failed, as there is insufficient safety data and potential risks from systemic absorption of this vasoconstrictor medication.

Preferred Alternatives to Xylometazoline

The evidence strongly supports using safer first-line options before considering topical decongestants like Otrivin:

• Hypertonic saline nasal rinses are safe and effective for nasal congestion during pregnancy and should be the initial treatment 1
• Intranasal corticosteroids (budesonide, fluticasone, mometasone) are considered safe at recommended doses and are more effective than decongestants for chronic nasal symptoms 2
• First-generation antihistamines (chlorpheniramine) have extensive safety data with over 200,000 first-trimester exposures showing no increased teratogenic risk 3, 4

If Decongestants Are Necessary

When non-pharmacologic and safer pharmacologic options fail:

• Limit use to 3-7 days maximum to avoid rhinitis medicamentosa (rebound congestion) 5
• Use with extreme caution as decongestants have not been conclusively proven safe but may be used for short-term relief when no safer alternatives work 3
• Avoid in first trimester when organogenesis occurs and teratogenic risk is highest 2
• Consult with the patient's obstetrician before initiating treatment 2

Key Safety Concerns with Xylometazoline

The limited evidence on xylometazoline specifically raises several concerns:

• Insufficient human pregnancy data: No controlled studies exist examining xylometazoline safety during pregnancy 3, 4
• Systemic vasoconstriction risk: As a sympathomimetic agent, xylometazoline could theoretically affect uteroplacental blood flow, though this has not been definitively studied 5
• Addiction potential: Prolonged use can lead to severe rhinitis medicamentosa and even substance use disorder, making it particularly problematic during the extended pregnancy period 6

Clinical Algorithm

1. First-line: Saline nasal rinses (0.9% or hypertonic) - unlimited frequency 1
2. Second-line: Intranasal corticosteroids (budesonide preferred) for persistent symptoms 2
3. Third-line: First-generation oral antihistamines if allergic component present 3, 4
4. Last resort only: Short-course (≤7 days) topical decongestant with obstetric consultation 5

Important Caveats

• Rhinitis medicamentosa: The rebound congestion from decongestant overuse can be worse than the original symptoms and may persist throughout pregnancy if not recognized early 6
• Product confusion: Ensure patients understand the difference between saline sprays (safe, unlimited use) and medicated decongestant sprays (limited use) 1
• Maternal benefit vs. fetal risk: While undertreated maternal conditions can harm the fetus, the specific risks of xylometazoline remain poorly characterized compared to better-studied alternatives 7